30
Participants
Start Date
February 28, 2023
Primary Completion Date
March 1, 2025
Study Completion Date
March 1, 2028
Toripalimab
Toripalimab, 240 mg IV infusion on Day 1 of each 21 day cycle for 3 cycles prior to surgery and 3 cycles after surgery.
Trastuzumab
Trastuzumab, 8 mg/kg IV loading dose at 1st administration and then 6 mg/kg IV on Day 1 of each 21 day cycle for 3 cycles before surgery and 3 cycles after surgery. The first administration of trastuzumab after surgery should also be given at the loading dose of 8 mg/kg.
5-FU, leucovorin, docetaxel, oxaliplatin (FLOT)
"Pre-operative treatment 4 cycles and post-operative treatment 4 cycles:~Docetaxel 50 mg/m², IV on day 1 of each 14 day cycle; Oxaliplatin 85 mg/m² , IV on day 1 of each 14 day cycle; Leucovorin 200 mg/m² or Levoleucovorin 100 mg/m², IV on day 1 of each 14 day cycle; 5-FU 2600 mg/m², IV over 24 h on day 1 of each 14 day cycle."
RECRUITING
The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
NOT_YET_RECRUITING
The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
NOT_YET_RECRUITING
Huzhou Central Hospital, Huzhou
NOT_YET_RECRUITING
Ningbo First Hospital, Ningbo
NOT_YET_RECRUITING
Ningbo Medical Center LiHuiLi Hospital, Ningbo
NOT_YET_RECRUITING
Ningbo Second Hospital, Ningbo
NOT_YET_RECRUITING
Taizhou Hospital, Taizhou
NOT_YET_RECRUITING
Lishui Central Hospital, Lishui
Yu jiren
OTHER